Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Propanc Logo
Propanc Growth Score
71
CB Rank
54949
Heat Score
73
Propanc is a research and development company developing treatments for cancer and other chronic diseases.
Founded
obfuscation
PublicPost-IPO Equity Melbourne, Victoria, Australia1-10 propanc.com
Biotechnology
Developer Platform
Health Care
Health Diagnostics
Overview

Propanc
Total Funding
obfuscation
Growth Score
71
Heat Score
73

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score71
-16 pts
in past quarter
Heat Score 73
3 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Propanc

CB Rank
54949
Propanc is a research and development company developing treatments for cancer and other chronic diseases.
Founded
obfuscation
PublicPost-IPO Equity Melbourne, Victoria, Australia1-10 propanc.com
Biotechnology
Developer Platform
Health Care
Health Diagnostics

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name Propanc Biopharma, Inc.
Also Known As Propanc Health Group Corp
Operating Status Active
Stock Symbol  NASDAQ:PPCB
Company Type For Profit
Founders  James Nathanielsz, Julian Kenyon
About the Company
Propanc is a research and development company developing treatments for cancer and other chronic diseases. The company focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer.
Phone Number +61 (0)3 9614 2795
Contact Email info@propanc.com
Predictions & Insights

Growth Insight

See this Growth Insight
Propanc is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

PRP
A pancreatic proenzyme formulation designed to inhibit cancer cell migration, tumor blood vessel formation, and induce cancer cell death.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Propanc Logo
Post-IPO Equity - Propanc
1
obfuscation
Hexstone CapitalPost-IPO Equity
obfuscation
Post-IPO Equity - Propanc Logo
Post-IPO Equity - Propanc
1
obfuscation
Hexstone CapitalPost-IPO Equity
obfuscation
Post-IPO Equity - Propanc Logo
Post-IPO Equity - Propanc
1
obfuscation
Hexstone CapitalPost-IPO Equity
obfuscation
Post-IPO Equity - Propanc Logo
Post-IPO Equity - Propanc
1
obfuscation
Hexstone CapitalPost-IPO Equity
obfuscation
Post-IPO Equity - Propanc Logo
Post-IPO Equity - Propanc
1
obfuscation
Hexstone CapitalPost-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Propanc Logo
Post-IPO Equity - Propanc
1
obfuscation
Hexstone CapitalPost-IPO Equity
obfuscation
Post-IPO Equity - Propanc Logo
Post-IPO Equity - Propanc
1
obfuscation
Hexstone CapitalPost-IPO Equity
obfuscation
Post-IPO Equity - Propanc Logo
Post-IPO Equity - Propanc
1
obfuscation
Hexstone CapitalPost-IPO Equity
obfuscation
Post-IPO Equity - Propanc Logo
Post-IPO Equity - Propanc
1
obfuscation
Hexstone CapitalPost-IPO Equity
obfuscation
Post-IPO Equity - Propanc Logo
Post-IPO Equity - Propanc
1
obfuscation
Hexstone CapitalPost-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Hexstone Capital Logo
Hexstone Capital
Yes
Post-IPO Equity - Propanc Logo
Post-IPO Equity - Propanc
—
Hexstone Capital Logo
Hexstone Capital
Yes
Post-IPO Equity - Propanc Logo
Post-IPO Equity - Propanc
—
Hexstone Capital Logo
Hexstone Capital
Yes
Post-IPO Equity - Propanc Logo
Post-IPO Equity - Propanc
—
Hexstone Capital Logo
Hexstone Capital
Yes
Post-IPO Equity - Propanc Logo
Post-IPO Equity - Propanc
—
Hexstone Capital Logo
Hexstone Capital
Yes
Post-IPO Equity - Propanc Logo
Post-IPO Equity - Propanc
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 3

Employee Profiles

News

News and Press

News•Jun 2, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 19, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 15, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 14, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

350
60.55%
 in past month

Actively Used Products

16Propanc uses 16 technology products and services including HTML5, Office 365, and  jQuery, according to G2 Stack.

Active Website Tech Count

3Propanc is actively using 3 technologies for its website, according to BuiltWith. These include reCAPTCHA, CommonCrawl Top 5m, and  CommonCrawl Top 10m.

Total IP

9The intellectual property of Propanc includes 9 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Propanc's headquarters? Propanc is located in Melbourne, Victoria, Australia.Who invested in Propanc? Propanc is funded by Hexstone Capital.When was the last funding round for Propanc? Propanc closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Propanc's competitors? Alternatives and possible competitors to Propanc may include Tempest Therapeutics, Acrivon Therapeutics, and  Eisbach Bio.How much funding has Propanc raised to date? Propanc has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|